What is the catalog number for Rifampicin-d4?

The catalog number for Rifampicin-d4 is HY-B0272S2.

What sizes are available for Rifampicin-d4?

Rifampicin-d4 is available in the following size(s): 1 mg.

Is Rifampicin-d4 in stock?

Rifampicin-d4 is currently made to order / not held in immediate stock. Contact us for lead time.

Who manufactures Rifampicin-d4?

Rifampicin-d4 is manufactured by QuantiMol.

What is the estimated delivery time for Rifampicin-d4?

Estimated delivery time for Rifampicin-d4 is approximately 15 business day(s), depending on your location.

Where can I find the safety data sheet (SDS/MSDS) for Rifampicin-d4?

The safety data sheet for Rifampicin-d4 is available here: http://file.medchemexpress.com/batch_PDF/HY-B0272S2/Rifampicin-d4-SDS-MedChemExpress.pdf.

Rifampicin-d4

Rifampicin-d4 is the deuterium labeled Rifampicin. Rifampicin is a potent and broad spectrum antibiotic against bacterial pathogens. Rifampicin has anti-influenza virus activities.

Product Specifications

Product Name Alternative

Rifampin-d4; Rifamycin AMP-d4

UNSPSC

12352005

Hazard Statement

H302, H362

Target

Antibiotic; Bacterial; Influenza Virus; Isotope-Labeled Compounds

Type

Isotope-Labeled Compounds

Related Pathways

Anti-infection; Others

Field of Research

Infection

Purity

99.69

Solubility

DMF : ≥ 20mg/mL|DMSO : ≥ 3.3mg/mL|Ethanol : ≥ 0.12mg/mL

Smiles

OC(C(/C=N/N1C([2H])([2H])CN(C)CC1([2H])[2H])=C(NC(/C(C)=C\C=C\[C@@H]([C@@H]([C@@H](C)[C@H]2O)O)C)=O)C(O)=C3C(O)=C4C)=C3C5=C4O[C@](C)(O/C=C/[C@@H]([C@H]([C@@]([C@@H]2C)([H])OC(C)=O)C)OC)C5=O

Molecular Formula

C43H54D4N4O12

Molecular Weight

826.96

Precautions

H302, H362

References & Citations

[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216. |[2]Hamzehei M, et al. Inhibition of influenza A virus replication by rifampicin and selenocystamine. J Med Virol. 1980;6 (2) :169-74.|[3]Piriou A, et al. Fatty liver induced by high doses of rifampicin in the rat: possible relation with an inhibition of RNA polymerases in eukariotic cells. Arch Toxicol Suppl. 1979; (2) :333-7.|[4]Erokhina MV, et al. [In vitro development of rifampicin resistance in the epithelial cells]. Probl Tuberk Bolezn Legk. 2006; (8) :58-61.|[5]Yu J, et al. Monitoring in vivo fitness of rifampicin-resistant Staphylococcus aureus mutants in a mouse biofilm infection model. J Antimicrob Chemother. 2005 Apr;55 (4) :528-34. Epub 2005 Mar 2.